Equity grants to Schrodinger (NASDAQ: SDGR) officer include options and RSUs

Rhea-AI Filing Summary

Schrodinger, Inc. officer Mannix Vartan Aklian reported equity awards consisting of stock options and restricted stock units under the company’s 2022 Equity Incentive Plan, as amended. The filing shows a grant of 34,250 stock options at an exercise price of $0.00 per share, with 25% of the underlying shares scheduled to vest on March 2, 2027 and the remaining shares vesting in equal monthly installments through March 2, 2030, subject to continued service.

In addition, Aklian received a grant of 17,130 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock. These RSUs were granted on March 2, 2026 and are scheduled to vest in equal installments on March 9, 2027, 2028, 2029 and 2030, also subject to continued service with the company. Following this grant, the reporting person holds 31,193 unvested RSUs in total.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aklian Mannix Vartan

(Last) (First) (Middle)

C/O SCHRODINGER, INC.,

1540 BROADWAY, 24TH FLOOR

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Schrodinger, Inc. [ SDGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/02/2026		A		17,130	A	$0	31,193(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$12.15	03/02/2026		A		34,250		(3)	03/02/2036	Common Stock	34,250	$0	34,250	D

Explanation of Responses:

1. Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 2, 2026 and will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, subject to the reporting person's continued service with the company.

2. Includes 31,193 unvested RSUs.

3. The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030, subject to the reporting person's continued service with the company.

Remarks:

EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing

	/s/ Donald Shum, as attorney-in-fact for Mannix Vartan Aklian	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did SDGR report for Mannix Vartan Aklian?

Schrodinger, Inc. reported that officer Mannix Vartan Aklian received grants of stock options and restricted stock units on March 2, 2026. These awards were issued under the company’s 2022 Equity Incentive Plan, reflecting equity-based compensation rather than open-market share purchases or sales.

How many stock options were granted to the SDGR officer in this Form 4?

The officer received a grant of 34,250 stock options with an exercise price of $0.00 per share. Twenty-five percent of the underlying shares are scheduled to vest on March 2, 2027, with the remaining shares vesting monthly through March 2, 2030, subject to continued service.

What restricted stock units (RSUs) did SDGR grant in this Form 4 filing?

Schrodinger granted 17,130 restricted stock units to the reporting officer on March 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest in four equal installments on March 9 of 2027, 2028, 2029, and 2030, contingent on continued service.

What is the vesting schedule for the SDGR stock options granted on March 2, 2026?

The option grant vests 25% of the shares on March 2, 2027, with the remaining shares vesting in equal monthly installments through March 2, 2030. All vesting is conditioned on the reporting person’s continued service with Schrodinger throughout the vesting period.

What is the vesting schedule for the Schrodinger (SDGR) RSUs granted in this Form 4?

The RSUs granted on March 2, 2026 vest in four equal annual installments. Vesting dates are March 9, 2027, March 9, 2028, March 9, 2029, and March 9, 2030, and each installment requires the officer to remain in service with the company until that date.

How many unvested RSUs does the SDGR reporting person hold after these grants?

After the reported grant, the officer holds 31,193 unvested restricted stock units. This total reflects RSUs that have been awarded but not yet vested, meaning they are still subject to vesting conditions tied to continued service with Schrodinger, Inc.